160 related articles for article (PubMed ID: 9537812)
1. Evidence for the involvement of the nitric oxide-cGMP pathway in the antinociception of morphine in the formalin test.
Granados-Soto V; Rufino MO; Gomes Lopes LD; Ferreira SH
Eur J Pharmacol; 1997 Dec; 340(2-3):177-80. PubMed ID: 9537812
[TBL] [Abstract][Full Text] [Related]
2. Reduction in [D-Ala2, NMePhe4, Gly-ol5]enkephalin-induced peripheral antinociception in diabetic rats: the role of the L-arginine/nitric oxide/cyclic guanosine monophosphate pathway.
Tasatargil A; Sadan G
Anesth Analg; 2004 Jan; 98(1):185-192. PubMed ID: 14693616
[TBL] [Abstract][Full Text] [Related]
3. Evidence that nitric oxide-glutamate cascade modulates spinal antinociceptive effect of morphine: a behavioural and microdialysis study in rats.
Watanabe C; Okuda K; Sakurada C; Ando R; Sakurada T; Sakurada S
Brain Res; 2003 Nov; 990(1-2):77-86. PubMed ID: 14568332
[TBL] [Abstract][Full Text] [Related]
4. Involvement of L-arginine/NO/cGMP/K(ATP) channel pathway in the peripheral antinociceptive actions of ellagic acid in the rat formalin test.
Ghorbanzadeh B; Mansouri MT; Hemmati AA; Naghizadeh B; Mard SA; Rezaie A
Pharmacol Biochem Behav; 2014 Nov; 126():116-21. PubMed ID: 25278343
[TBL] [Abstract][Full Text] [Related]
5. Participation of the nitric oxide-cyclic GMP-ATP-sensitive K(+) channel pathway in the antinociceptive action of ketorolac.
Lázaro-Ibáñez GG; Torres-López JE; Granados-Soto V
Eur J Pharmacol; 2001 Aug; 426(1-2):39-44. PubMed ID: 11525769
[TBL] [Abstract][Full Text] [Related]
6. The antinociceptive activity of Muntingia calabura aqueous extract and the involvement of L-arginine/nitric oxide/cyclic guanosine monophosphate pathway in its observed activity in mice.
Zakaria ZA; Sulaiman MR; Jais AM; Somchit MN; Jayaraman KV; Balakhrisnan G; Abdullah FC
Fundam Clin Pharmacol; 2006 Aug; 20(4):365-72. PubMed ID: 16867020
[TBL] [Abstract][Full Text] [Related]
7. Role of L-arginine/nitric oxide pathway in the antinociceptive activities of morphine and mepyramine in mice.
Abacioğlu N; Ozmen R; Cakici I; Tunçtan B; Kanzik I
Arzneimittelforschung; 2001; 51(12):977-83. PubMed ID: 11799845
[TBL] [Abstract][Full Text] [Related]
8. Ketamine activates the L-arginine/Nitric oxide/cyclic guanosine monophosphate pathway to induce peripheral antinociception in rats.
Romero TR; Galdino GS; Silva GC; Resende LC; Perez AC; Côrtes SF; Duarte ID
Anesth Analg; 2011 Nov; 113(5):1254-9. PubMed ID: 21788321
[TBL] [Abstract][Full Text] [Related]
9. Role of nitric oxide in the rat hippocampal CA1 in morphine antinociception.
Hashemi M; Karami M; Zarrindast MR; Sahebgharani M
Brain Res; 2010 Feb; 1313():79-88. PubMed ID: 19931515
[TBL] [Abstract][Full Text] [Related]
10. The spinal antinociceptive effect of FR140423 is mediated through kyotorphin receptors.
Ochi T; Motoyama Y; Goto T
Life Sci; 2000; 66(23):2239-45. PubMed ID: 10855944
[TBL] [Abstract][Full Text] [Related]
11. Morphine-induced antinociception in the formalin test: sensitization and interactions with D1 and D2 dopamine receptors and nitric oxide agents.
Zarrindast MR; Asgari-Afshar A; Sahebgharani M
Behav Pharmacol; 2007 May; 18(3):177-84. PubMed ID: 17426481
[TBL] [Abstract][Full Text] [Related]
12. Sildenafil, a phosphodiesterase-5 inhibitor, enhances the antinociceptive effect of morphine.
Jain NK; Patil CS; Singh A; Kulkarni SK
Pharmacology; 2003 Mar; 67(3):150-6. PubMed ID: 12571411
[TBL] [Abstract][Full Text] [Related]
13. Evidence for the participation of the nitric oxide-cyclic GMP pathway in the antinociceptive action of meloxicam in the formalin test.
Aguirre-Bañuelos P; Granados-Soto V
Eur J Pharmacol; 2000 Apr; 395(1):9-13. PubMed ID: 10781667
[TBL] [Abstract][Full Text] [Related]
14. The role of L-arginine/nitric oxide pathway in the antinociceptive activity of pyridoxine in mouse.
Abacioğlu N; Tunçtan B; Cakici I; Akbulut E; Uludağ O; Kanzik I
Arzneimittelforschung; 2001 Oct; 51(10):832-8. PubMed ID: 11715636
[TBL] [Abstract][Full Text] [Related]
15. The kappa-opioid agonist (+/-)-bremazocine elicits peripheral antinociception by activation of the L-arginine/nitric oxide/cyclic GMP pathway.
Amarante LH; Duarte ID
Eur J Pharmacol; 2002 Nov; 454(1):19-23. PubMed ID: 12409000
[TBL] [Abstract][Full Text] [Related]
16. L-NAME causes antinociception by stimulation of the arginine-NO-cGMP pathway.
Duarte ID; Ferreira SH
Mediators Inflamm; 2000; 9(1):25-30. PubMed ID: 10877451
[TBL] [Abstract][Full Text] [Related]
17. Role of guanylyl cyclase activation via thiamine in suppressing chemically-induced writhing in mouse.
Abacioğlu N; Demir S; Cakici I; Tunçtan B; Kanzik I
Arzneimittelforschung; 2000 Jun; 50(6):554-8. PubMed ID: 10918950
[TBL] [Abstract][Full Text] [Related]
18. alpha(2)-Adrenoceptor agonist xylazine induces peripheral antinociceptive effect by activation of the L-arginine/nitric oxide/cyclic GMP pathway in rat.
Romero TR; Duarte ID
Eur J Pharmacol; 2009 Jun; 613(1-3):64-7. PubMed ID: 19389395
[TBL] [Abstract][Full Text] [Related]
19. Participation of the components of L-arginine/nitric oxide/cGMP cascade by chemically-induced abdominal constriction in the mouse.
Abacioğlu N; Tunçtan B; Akbulut E; Cakici I
Life Sci; 2000; 67(10):1127-37. PubMed ID: 10954047
[TBL] [Abstract][Full Text] [Related]
20. Involvement of N-methyl-D-aspartate receptors and nitric oxide in the rostral ventromedial medulla in modulating morphine pain-inhibitory signals from the periaqueductal grey matter in rats.
Javanmardi K; Parviz M; Sadr SS; Keshavarz M; Minaii B; Dehpour AR
Clin Exp Pharmacol Physiol; 2005 Jul; 32(7):585-9. PubMed ID: 16026519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
